| Pharmaceutical Information |
| Drug Name |
Deferiprone |
| Drug ID |
BADD_D00595 |
| Description |
Deferiprone is an oral iron chelator used as a second line agent in thalassemia syndromes when iron overload from blood transfusions occurs. Thalassemias are a type of hereditary anaemia due a defect in the production of hemoglobin. As a result, erythropoiesis, the production of new red blood cells, is impaired. FDA approved on October 14, 2011. |
| Indications and Usage |
Deferiprone is indicated in thalassemia syndromes when first line chelation agents are not adequate to treat transfusional iron overload. |
| Marketing Status |
approved |
| ATC Code |
V03AC02 |
| DrugBank ID |
DB08826
|
| KEGG ID |
D07416
|
| MeSH ID |
D000077543
|
| PubChem ID |
2972
|
| TTD Drug ID |
D0N0OU
|
| NDC Product Code |
17349-0023; 10122-103; 0054-0711; 10122-100; 51672-4196; 10122-104; 10122-101; 0054-0576; 52609-4502 |
| UNII |
2BTY8KH53L
|
| Synonyms |
Deferiprone | 1,2-Dimethyl-3-hydroxy-4-pyridinone | 1,2 Dimethyl 3 hydroxy 4 pyridinone | DMOHPO | 1,2-Dimethyl-3-hydroxypyrid-4-one | 1,2 Dimethyl 3 hydroxypyrid 4 one | 3-Hydroxy-1,2-dimethyl-4-pyridinone | 3 Hydroxy 1,2 dimethyl 4 pyridinone | HDMPP | 1,2-Dimethyl-3-hydroxypyridin-4-one | 1,2 Dimethyl 3 hydroxypyridin 4 one | Ferriprox |
|
| Chemical Information |
| Molecular Formula |
C7H9NO2 |
| CAS Registry Number |
30652-11-0 |
| SMILES |
CC1=C(C(=O)C=CN1C)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
